Let’s Discover Together.

Target-Specific Assays

Assays for drug screening against 1000+ targets

Cell-Based Assays

Drug testing in the physiological environment of intact cells.

Biophysical Assays

Elucidate the mechanism of action of drug candidates on a molecular level.

In Vivo Pharmacology

Tumor models to reliably test the potency of drug candidates in mice.

ADME & Safety

Pharmacological testing to provide a basis for preclinical candidate selection.

COVID-19 Assays

Supporting your quest for a new therapeutic to treat COVID-19

Recombinant Proteins

Recombinant proteins and substrates for drug discovery research.

Popular Services

Fast track to our most popular drug discovery services.

What people are saying

I have worked with Reaction Biology Europe and Reaction Biology Corp. for more than 5 years on several interesting projects. These have ranged from routine enzyme screening to more complex kinome-scan and in-cell target engagement work. The results of these endeavours have led to series of top tier publications. This coupled with exceptional customer service means I have no hesitation to recommend Reaction Biology Corp. and Reaction Biology Europe as research partners.

Laurent Meijer
Chair & CSO, Perha Pharmaceuticals & ManRos Therapeutics
ManRos Therapeutics ManRos Therapeutics

Who we are.

Our clients are seeking answers in their quest to discover effective treatments for patients. Finding these answers is our mission. Our method is to accelerate the drug discovery process with the widest possible range of assays and services but also to maintain an integrated view of the journey to a lead drug candidate. We strive to provide excellent data, delivered in a timely, collaborative manner by outstanding scientists. Who are we? We’re your partner.
 
Let’s Discover Together.

About us

Meet Us at Our Next Event

Virtual from San Francisco, USA
, 11:00pm - , 10:59pm

PREDiCT: Tumor Models

Join us to learn about innovative tumor models for oncology drug discovery.

Join us
San Diego view
Virtual from San Diego, CA, USA
, 10:00pm - , 9:59pm

Drug Discovery Chemistry

Learn about strategies for small molecule compound development in the targeted approach.

Join us
Virtual from Washington, DC
, 10:00pm - , 9:59pm

AACR Annual Meeting

Get up to date on the latest discoveries in cancer research.

Join us
Virtual from the UK
, 10:00pm - , 9:59pm

RSC/SCI symposium on kinase inhibitor design

Join us to learn about new approaches and case studies in the kinase drug discovery field.

Join us
Virtual from Barcelona, ES
, 10:00pm - , 9:59pm

European Oncology Partnering Convention

Expand your network and meet new people in the oncology field.

Join us
London, UK
, 10:00pm - , 9:59pm

Immuno Series UK

Join us at our first in-person meeting this year to explore our immuno-oncology platform.

Join us
London, UK
, 10:00pm - , 9:59pm

Discovery Series UK

An in-person event to meet our scientists heading our biophysical and KRAS-related service units…

Join us

Latest News

COVID-19 /SARS-CoV2 update

Dear customers,

all Reaction Biology research facilities are and remain fully operational under safe work environment guidelines. Our business will not close due to lockdown restrictions in Europe. Our sales staff and business development team are happy to discuss any project with you. Please reach out!

More

Cooperation with 4HF Biotec to provide new Bioinformatic Cell Service

In cooperation with the bioinformatics firm 4HF Biotec, we announce the offering of a combination of the ProLiFiler cell panel screening service with 4HF‘s bioinformatic evaluation of the drug‘s profile.

Download Press Release

ProQinase is now Reaction Biology Europe

ProQinase rebranding into Reaction Biology Europe GmbH was performed completing the process of acquiring ProQinase. As this only represents a change of name, all contracts with former ProQinase remain valid and binding. All ProQinase products and services are continued and available within the Reaction Biology portfolio.

More